Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Immunology (Baltimore, Md. : 1950)|April 18, 2018
Development of Dengue Virus Serotype-Specific NS1 Capture Assays for the Rapid and Highly Sensitive Identification of the Infecting Serotype in Human SeraKatharina Röltgen, Natalie Rose, Alessia Ruggieri, et al.Malaria Journal|January 1, 2010
Design and pre-clinical profiling of a Plasmodium falciparum MSP-3 derived component for a multi-valent virosomal malaria vaccineMarco Tamborrini, Markus S Mueller, Sabine A Stoffel, et al.Vaccines|October 27, 2015
A Synthetic Virus-Like Particle Streptococcal Vaccine Candidate Using B-Cell Epitopes from the Proline-Rich Region of Pneumococcal Surface Protein AMarco Tamborrini, Nina Geib, Aniebrys Marrero-Nodarse, et al.Chembiochem : a European Journal of Chemical Biology|December 7, 2010
Engineered synthetic virus-like particles and their use in vaccine deliveryArin Ghasparian, Tina Riedel, Jimy Koomullil, et al.Journal of Bacteriology|May 17, 2011
Identification of an African Bacillus anthracis lineage that lacks expression of the spore surface-associated anthrose-containing oligosaccharideMarco Tamborrini, Mark Bauer, Miriam Bolz, et al.Frontiers in Bioengineering and Biotechnology|June 7, 2022
Scalable Process for High-Yield Production of PfCyRPA Using Insect Cells for Inclusion in a Malaria Virosome-Based Vaccine CandidateBárbara Fernandes, Marcos Sousa, Rute Castro, et al.Journal of the American Chemical Society|July 10, 2010
Molecular analysis of carbohydrate-antibody interactions: case study using a Bacillus anthracis tetrasaccharideMatthias A Oberli, Marco Tamborrini, Yu-Hsuan Tsai, et al.BMC Biotechnology|November 24, 2016
Generation of monoclonal antibodies against native viral proteins using antigen-expressing mammalian cells for mouse immunizationNatalie Rose, Carlos Augusto Pinho-Nascimento, Alessia Ruggieri, et al.Elife|February 15, 2017
Structure of the malaria vaccine candidate antigen CyRPA and its complex with a parasite invasion inhibitory antibodyPaola Favuzza, Elena Guffart, Marco Tamborrini, et al.Cell Reports|April 4, 2024
The essential malaria protein PfCyRPA targets glycans to invade erythrocytesChristopher J Day, Paola Favuzza, Sabrina Bielfeld, et al.Pageof 2